Share
Journal Information
Most Often Read
814
Current concepts in acute liver failureMaximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
814
Open access
698
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller
Ann Hepatol. 2019;18:518-35
698
Open access
549
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)Sebastião M.B. Duarte, Jose Tadeu Stefano, Claudia P. Oliveira
Ann Hepatol. 2019;18:416-21
549
Open access
509
Endoscopic retrograde cholangiopancreatography versus surgery for choledocholithiasis – A meta-analysisFernando C. Schacher, Sofia M. Giongo, Fernanda J.P. Teixeira, Ângelo Z. Mattos
Ann Hepatol. 2019;18:595-600
509
Open access
433
Liver disease in pregnancy: Medical aspects and their implications for mother and childCarmen Selene García-Romero, Carolina Guzman, Alicia Cervantes, Marco Cerbón
Ann Hepatol. 2019;18:553-62
433
Open access
371
Hepatitis E and chronic liver damage in apparently immunocompetent individuals: Now what?Santiago Mirazo, Juan Arbiza
Ann Hepatol. 2019;18:539-40
371
Open access
344
Antioxidants benefits in hepatitis C infection in the new DAAs eraSonia A. Lozano-Sepúlveda, Ana R. Rincón-Sanchez, Ana M. Rivas-Estilla
Ann Hepatol. 2019;18:410-5
344
Open access
326
First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in MexicoOliver Viera-Segura, Mauricio Realpe-Quintero, Arturo Panduro, Sonia Roman, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Jorge L. Trujillo-Ochoa, Nora A. Fierro
Ann Hepatol. 2019;18:571-7
326
Open access
312
Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomesAbdulrahman A. Aljumah, Hamad Al-Ashgar, Hind Fallatah, Ali Albenmousa
Ann Hepatol. 2019;18:439-44
312
Open access
294
Hepatitis E in Latin AmericaRosa Elena Sarmiento-Silva, Francisco Arenas-Huertero
Ann Hepatol. 2019;18:541-2
294
Open access
277
The basis of liver regeneration: A systems biology approachMamatha Bhat, Elisa Pasini, Cristina Baciu, Marc Angeli, Atul Humar, Sonya Macparland, Jordan Feld, Ian McGilvray
Ann Hepatol. 2019;18:422-8
277
Open access
271
Genome-based nutritional strategies to prevent chronic liver diseaseSonia Roman
Ann Hepatol. 2019;18:537-8
271
Open access
269
Non-alcoholic fatty liver disease and neurological defectsRita Moretti, Paola Caruso, Silvia Gazzin
Ann Hepatol. 2019;18:563-70
269
Open access
266
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)Cristiane V. Tovo, Cristiane A. Villela-Nogueira, Nathalie C. Leite, Carine L. Panke, Gabriela Z. Port, Sabrina Fernandes, Caroline Buss, Gabriela P. Coral, Ana C. Cardoso, Claudia M. Cravo, Fernanda L. Calçado, Guilherme F.M. Rezende, Frederico C. Ferreira, João M. Araujo-Neto, Renata de M. Perez, Henrique S. Moraes-Coelho, Angelo A. de Mattos
Ann Hepatol. 2019;18:445-9
266
Open access
246
Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessmentAlejandra Cano-Paniagua, Pedro Amariles, Nancy Angulo, Margarita Restrepo-Garay
Ann Hepatol. 2019;18:501-7
246
Open access
244
Vasoconstrictors in hepatorenal syndrome – A critical reviewÂngelo Z. Mattos, Fernando C. Schacher, Angelo A. Mattos
Ann Hepatol. 2019;18:287-90
244
Open access
239
Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis featuresFernando Mané, Hélder Cardoso, Rodrigo Liberal, Susana Lopes, Pedro Pereira, Regina Gonçalves, Guilherme Macedo
Ann Hepatol. 2019;18:488-93
239
Open access
238
The relationship between coagulation disorders and the risk of bleeding in cirrhotic patientsAsma Labidi, Héla Baccouche, Monia Fekih, Sonia Mahjoub, Nadia BenMustapha, Meriem Serghini, Neila BenRomdhane, Jalel Boubaker
Ann Hepatol. 2019;18:627-32
238
Open access
236
Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?Filiz Akyüz, Bilger Çavuş, Binnur Pınarbaşı, Mürvet Bozacı, Bülent Baran, Umit Akyuz, Ahmet Uyanıkoglu, Kadir Demir, Fatih Beşışık, Sadakat Özdil, Güngör Boztaş, Zeynel Mungan, Selim Badur, Sadi Yenen, Sabahattin Kaymakoglu
Ann Hepatol. 2019;18:585-9
236
Open access
Publish in
Annals of Hepatology
Affiliated societies
